Vera Chotzen, MD
Procedural Dermatology · Sacramento, CANPI 1427166016
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 121 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by AbbVie at 57.1% of the total. Reporting peaked in 2019 at $1,232 and has fallen 80.3% since, to $243 in 2025. That places this record below the midpoint for procedural dermatology clinicians in CA, where the typical reported total is $2,566.
Across 121 payments — averaging $24.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Revance Therapeutics, Inc.$262
- Galderma Laboratories, L.p.$248
- Janssen Scientific Affairs, LLC$125
- Novartis$123
- Pfizer$108
- plus $389 from 8 others
What the payments were for
- Food & beverage$2,922100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 86 | $1,667 |
| Revance Therapeutics, Inc. | 9 | $262 |
| Galderma Laboratories, L.p. | 13 | $248 |
| Janssen Scientific Affairs, LLC | 1 | $125 |
| Novartis | 1 | $123 |
| Pfizer | 1 | $108 |
| Lilly USA, LLC | 2 | $92 |
| Sun Pharmaceutical Industries Inc. | 1 | $84 |
| Sientra, Inc. | 1 | $69 |
| UCB, Inc. | 1 | $50 |
| Merz North America, Inc. | 1 | $48 |
| Pierre Fabre Pharmaceuticals, Inc. | 2 | $18 |
| Prugen, Inc. Pharmaceuticals | 1 | $15 |
| Mission Pharmacal Company | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tremfya$125
- COSENTYX$123
- EUCRISA$108
- Skyrizi$100
- BOTOX COSMETIC$100
How this compares
$2,922 in reported general payments places this provider in the 50th percentile of 108 procedural dermatology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Acyclovir | 23 | $362 |
| Triamcinolone Acetonide | 11 | $73 |
Paid to pharmacies, not to this prescriber.
Other procedural dermatology in Sacramento
- Suzanne KilmerSacramento$220K
- Susan SilvaSacramento$116K
- Margaret ParsonsSacramento$3K
- Sam Khalifianla Mesa$3.5M
- Sabrina FabiSan Diego$3.1M
- Natasha MesinkovskaMission Viejo$499K
- Jeanette BlackLos Angeles$492K
- Mitchel GoldmanSan Diego$425K
- Rebecca FitzgeraldLos Angeles$230K
- Zakia RahmanStanford$181K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.